v3.26.1
Revenue - Schedule of Disaggregation of Net Sales by Market Geography (Details) - USD ($)
$ in Millions
 12 Months Ended
Apr. 24, 2026
Apr. 25, 2025
Apr. 26, 2024
Disaggregation of Revenue [Line Items]      
Total net sales $ 36,364 $ 33,537 $ 32,364
Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 33,079 30,734 29,654
Other Adjustments      
Disaggregation of Revenue [Line Items]      
Total net sales 39 (90) 0
U.S.      
Disaggregation of Revenue [Line Items]      
Total net sales 18,103 17,171 16,562
U.S. | Other Adjustments      
Disaggregation of Revenue [Line Items]      
Total net sales 0 0 0
Non-US      
Disaggregation of Revenue [Line Items]      
Total net sales 18,261 16,365 15,802
Non-US | Other Adjustments      
Disaggregation of Revenue [Line Items]      
Total net sales 39 (90) 0
Reportable segment net sales | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 33,079 30,734 29,654
Reportable segment net sales | U.S. | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 17,088 16,181 15,619
Reportable segment net sales | Non-US | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 15,991 14,553 14,035
Cardiovascular | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 13,976 12,481 11,831
Cardiovascular | U.S. | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 6,435 5,804 5,597
Cardiovascular | Non-US | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 7,541 6,677 6,234
Neuroscience | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 10,287 9,846 9,406
Neuroscience | U.S. | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 6,875 6,713 6,305
Neuroscience | Non-US | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 3,412 3,133 3,101
Medical Surgical | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 8,815 8,407 8,417
Medical Surgical | U.S. | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 3,778 3,664 3,717
Medical Surgical | Non-US | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 5,037 4,744 4,700
Diabetes | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 3,112 2,755 2,488
Diabetes | U.S. | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 934 923 852
Diabetes | Non-US | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 2,178 1,832 1,636
Other Operating Segments | U.S. | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales 81 68 91
Other Operating Segments | Non-US | Operating Segments      
Disaggregation of Revenue [Line Items]      
Total net sales $ 54 $ 70 $ 131